🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Niagen Bioscience, Inc.

NAGE Healthcare
$3.17 +$0.11 (3.59%)
Market Cap: $251.36 M
Gurus Holding
5
Popularity Rank
#1843
% of Shares Held
1.64%
Net Activity (Q2 2026)
-$3.9 M

Guru Ownership Trend

Guru Analysis for Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience, Inc. (NAGE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.13 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.9 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Mario Gabelli reduced exposure by 55.9%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$313,347
Total Buy Value
New Buys 2
Additions 0
-$4.21 M
Total Sell Value
Reductions 3
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Niagen Bioscience, Inc. (NAGE)

Major holders include Renaissance Technologies (RenTech) ($2.1 M), Cliff Asness ($1.51 M), Paul Tudor Jones ($274,528). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.3 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.9 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited NAGE. The total reported sell value was $4.21 M.

Yes, 2 managers opened new positions in NAGE, and 0 increased their existing holdings. The total reported buy value was $313,347.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -50.4% 659,584 $2.1 M Q2 2026
0.00% Reduce -54.2% 472,056 $1.51 M Q2 2026
0.00% New Buy 86,059 $274,528 Q2 2026
0.00% Reduce -55.9% 72,700 $231,913 Q2 2026
0.00% New Buy 12,169 $38,819 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form